Blood and urinary concentrations of salbutamol in asthmatic subjects

Medicine and Science in Sports and Exercise

Volumn 42, Issue 2, 2010, Pages 244-249

  Elers, Jimmi ^a   Pedersen, Lars ^a   Henninge, John ^b   Lund, Thomas K ^a   Hemmersbach, Peter ^b   Dalhoff, Kim ^a   Backer, Vibeke ^a  

^a BISPEBJERG HOSPITAL   (Denmark)

^b AKER UNIVERSITY HOSPITAL   (Norway)

Author keywords

2 agonists; Asthma; Doping; Pharmacokinetics

Indexed keywords

BRONCHODILATING AGENT; SALBUTAMOL;

ADOLESCENT; ADULT; ARTICLE; ASTHMA; BLOOD; COMPARATIVE STUDY; CROSSOVER PROCEDURE; DENMARK; DOPING; HUMAN; INHALATIONAL DRUG ADMINISTRATION; LUNG FUNCTION TEST; MALE; MIDDLE AGED; ORAL DRUG ADMINISTRATION; QUESTIONNAIRE; URINE;

ADMINISTRATION, INHALATION; ADMINISTRATION, ORAL; ADOLESCENT; ADULT; ALBUTEROL; ASTHMA; BRONCHODILATOR AGENTS; CROSS-OVER STUDIES; DENMARK; DOPING IN SPORTS; HUMANS; MALE; MIDDLE AGED; QUESTIONNAIRES; RESPIRATORY FUNCTION TESTS; YOUNG ADULT;

EID: 75149173036     PISSN: 01959131     EISSN: 15300315     Source Type: Journal    
DOI: 10.1249/MSS.0b013e3181b2e87d     Document Type: Article

References (19)

1. American Thoracic Society, European Respiratory Society. ATS/ ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005. Am J Respir Crit Care Med. 2005; 171:912-930
2. The Global Initiative for Asthma Web site [Internet]. USA: Global strategy for asthma management and prevention; [cited 2008 Aug]. Available from: http://www.ginasthma.org.
3. Anderson PJ. Pharmacokinetics of (R,S)-albuterol after aerosol inhalation in healthy adult volunteers. J Pharm Sci. 1998;87(7): 841-844
4. 2-Agonists and exercise-induced bronchoconstriction. Clin Rev Allergy Immunol. 2006;31: 163-180
5. Bateman ED, Hurd SS, Barnes PJ, et al. Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J. 2008;31:143-178
6. Berges R, Segura J, Ventura R, et al. Discrimination of prohibited oral use of salbutamol from authorized inhaled asthma treatment. Clin Chem. 2000;46:1365-1375
7. Carlsen KH, Anderson SD, Bjermer L, et al. Treatment of exercise-induced bronchoconstriction, respiratory and allergic disorders in sports and the relationship to doping: Part II of the report from the Joint Task Force of European Respiratory Society (ERS) and European Academy of Allergy and Clinical Immunology (EAACI) in cooperation with GA(2)LEN. Allergy. 2008; 63:492-505.
8. Dreborg S. The Skin Prick Test: Methodological Studies and Clinical Applications [Dissertation]. Linköping (Sweden): Link-öping University; 1987. p. 148.
9. Helenius IJ, Tikkanen HO, Haahtela T. Association between type of training and risk of asthma in elite athletes. Thorax. 1997;52: 157-160
10. Helenius IJ, Tikkanen HO, Sarna S, Haahtela T. Asthma and increased bronchial responsiveness in elite athletes: atopy and sport event as risk factors. J Allergy Clin Immunol. 1998;101: 646-652
11. Juniper EF, O'Byrne PM, Guyatt GH, Ferrie PJ, King DR. Development and validation of a questionnaire to measure asthma control. Eur Respir J. 1999;14:902-907
12. Langdeau JB, Turcotte H, Bowie DM, Jobin J, Desgagne P, Boulet LP. Airway hyperresponsiveness in elite athletes. Am J Respir Crit Care Med. 2000;161:1479-1484
13. Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J. 2005;26:319-338
14. Nysom K, Ulrik CS, Hesse B, Dirksen A. Published models and local data can bridge the gap between reference values of lung function for children and adults. Eur Respir J. 1997;10: 1591-1598
15. Pichon A, Venisse N, Krupka E, Pérault-Pochat M-C, Denjean A. Urinary and blood concentrations of A-2-agonists in trained subject: comparison between routes of use. Int J Sports Med. 2006;27:187-192
16. Sporer BC, Sheel AW, McKenzie DC. Dose response of inhaled salbutamol on exercise performance and urine concentrations. Med Sci Sports Exerc. 2008;40(1):149-157
17. Sporer BC, Sheel AW, Taunton J, Rupert JL, McKenzie DC. Inhaled salbutamol and doping control: effects of dose on urine concentrations. Clin J Sport Med. 2008;18(3):282-285
18. Thomsen SF, Ulrik CS, Larsen K, Backer V. Change in prevalence of asthma in Danish children and adolescents. Ann Allergy Asthma Immunol. 2004;92:506-511
19. Ventura R, Segura J, Berges R, et al. Distinction of inhaled and oral salbutamol by urine analysis using conventional screening procedures for doping control. Ther Drug Monit. 2000;22: 277-282